Article
Translational readthrough as a potential therapeutic for AIPL1-associated Leber Congenital…
medRxiv · 2021 · Amy Leung
Key facts
| Title | Translational readthrough as a potential therapeutic for AIPL1-associated Leber Congenital Amaurosis in a patient-derived iPSC-retinal organoid model |
|---|---|
| First author | Amy Leung |
| Journal | medRxiv |
| Published | Dec 18, 2021 |
| DOI | 10.1101/2021.12.17.473147 |
| Devices mentioned | K101223, K113129, K121993, K152205, K172649, K173648, K181594, K182569, K192391, K201252, K223557, K240221 and 15 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 8 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1